How I treat Logo

howitreat.in

A user-friendly, frequently updated reference guide that aligns with international guidelines and protocols.

Home

Immunosuppressants

 

 Name    

Dose 

(Adults) 

 Dose

(Paediatric)

Precautions 

Tacrolimus 0.02mg/Kg- PO- BD. (Target Tacrolimus levels- 3-7ng/mL) Avoid with Amphotericin, W/F Diarrhea, nephrotoxicity, hypertension, hyperglycemia, hypomagnesemia, abdominal pain, neurotoxicity
Discontinue CSA 24 hrs prior to starting Tacrolimus
 Sirolimus 5mg-OD  W/F Peripheral edema, hyperlipidaemia, decreased PL count, Progressive multifocal leukoencephalopathy, avoid with CSA/Tacro
 Ciclosporine 150-300mg- BD-PO
(2.5mg/kg- BD)
 

 Avoid with Amphotericin B, W/F- Tremors, nephrotoxicity,

Microangiopathy, hypertension, hirsutism, hypelipidemia, paraesthesia, TTP, Neurotoxicity with methyl prednisolone, monitor trough level (6am). Adjust dose accordingly.
IV dose is half the oral dose

 Mycophenolatemofetil 500-1000mg BD 1hr prior or 2 hrs after meals  Avoid with penicillin group antibiotics and other immunosuppressants.
Monitor BSL, Cholesterol, Mg, CBC, Ca, BP and K
W/F Diarrhoea and vomiting
Use double contraception and continue for 6 weeks after stopping.

 

 

Howitreat.in

Wish to Reach Hematologists?

Advertise with Us!

Know More

Howitreat.in

Wish to Reach Hematologists?

Advertise with Us!

Know More

Home

About Us

Support Us

Reports

An Initiative of

Veenadhare Edutech Private Limited

1299, 2nd Floor, Shanta Nivas,

Beside Hotel Swan Inn, Off J.M.Road, Shivajinagar

Pune - 411005

Maharashtra – India

How I treat Logo

howitreat.in

CIN: U85190PN2022PTC210569

Email: admin@howitreat.in

Disclaimer: Information provided on this website is only for medical education purposes and not intended as medical advice. Although authors have made every effort to provide up-to-date information, the recommendations should not be considered standard of care. Responsibility for patient care resides with the doctors on the basis of their professional license, experience, and knowledge of the individual patient. For full prescribing information, including indications, contraindications, warnings, precautions, and adverse effects, please refer to the approved product label. Neither the authors nor publisher shall be liable or responsible for any loss or adverse effects allegedly arising from any information or suggestion on this website. This website is written for use of healthcare professionals only; hence person other than healthcare workers is advised to refrain from reading the content of this website.